Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Exelixis, Inc. (EXEL) since 2002 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Exelixis, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 939767.
Total stock buying since 2002: $19,172,979.
Total stock sales since 2002: $314,392,814.
Total stock option exercises since 2002: $121,154,617.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 735,666 | $30,976,923 | 832,087 | $16,164,336 |
| 2024 | 615,000 | $12,666,910 | 872,432 | $24,870,534 | 1,184,849 | $27,369,242 |
| 2023 | 120,409 | $2,602,038 | 790,011 | $15,720,431 | 955,000 | $12,029,098 |
| 2022 | 0 | $0 | 436,562 | $8,413,845 | 525,000 | $2,574,050 |
| 2021 | 0 | $0 | 1,335,658 | $29,298,416 | 1,610,000 | $5,472,649 |
| 2020 | 0 | $0 | 2,145,329 | $47,948,063 | 4,262,623 | $19,133,251 |
| 2019 | 0 | $0 | 2,360,470 | $50,493,429 | 1,819,929 | $9,680,173 |
| 2018 | 0 | $0 | 1,561,698 | $32,260,917 | 1,448,858 | $7,586,210 |
| 2017 | 0 | $0 | 2,246,867 | $53,251,678 | 1,895,509 | $9,574,264 |
| 2016 | 60,000 | $297,920 | 795,219 | $11,897,846 | 1,152,332 | $8,539,362 |
| 2015 | 100,000 | $488,549 | 352,425 | $2,055,775 | 357,633 | $1,984,151 |
| 2014 | 20,000 | $34,200 | 0 | $0 | 23,914 | $0 |
| 2013 | 10,000 | $51,400 | 0 | $0 | 54,270 | $0 |
| 2012 | 35,000 | $156,795 | 7,000 | $35,917 | 54,271 | $0 |
| 2011 | 0 | $0 | 0 | $0 | 121,327 | $0 |
| 2010 | 482,700 | $1,489,754 | 108,539 | $835,207 | 104,427 | $570,120 |
| 2009 | 0 | $0 | 33,835 | $208,447 | 12,500 | $63,000 |
| 2008 | 392,500 | $1,276,125 | 27,213 | $188,239 | 0 | $0 |
| 2007 | 0 | $0 | 119,375 | $1,276,190 | 0 | $0 |
| 2006 | 0 | $0 | 205,624 | $2,114,980 | 65,624 | $414,711 |
| 2005 | 0 | $0 | 325,458 | $2,545,977 | 0 | $0 |
| 2004 | 10,000 | $85,388 | 0 | $0 | 0 | $0 |
| 2002 | 2,000 | $23,900 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-05 | 0 | $0 | 431,740 | $19,836,858 | 621,890 | $11,878,284 |
| 2025-03 | 0 | $0 | 10,000 | $388,000 | 0 | $0 |
| 2025-02 | 0 | $0 | 293,926 | $10,752,065 | 210,197 | $4,286,052 |
| 2024-11 | 0 | $0 | 288,574 | $10,102,873 | 226,300 | $4,254,439 |
| 2024-10 | 0 | $0 | 26,162 | $746,236 | 580,000 | $14,157,800 |
| 2024-09 | 0 | $0 | 25,000 | $659,500 | 0 | $0 |
| 2024-08 | 0 | $0 | 396,858 | $10,415,228 | 320,000 | $7,811,200 |
| 2024-06 | 0 | $0 | 8,287 | $182,314 | 0 | $0 |
| 2024-05 | 425,000 | $8,734,100 | 61,326 | $1,294,692 | 35,058 | $686,085 |
| 2024-03 | 0 | $0 | 19,205 | $461,112 | 23,491 | $459,718 |
| 2024-02 | 190,000 | $3,932,810 | 47,020 | $1,008,579 | 0 | $0 |
| 2023-12 | 0 | $0 | 114,149 | $2,612,602 | 50,000 | $814,500 |
| 2023-11 | 120,409 | $2,602,038 | 145,409 | $3,152,288 | 0 | $0 |
| 2023-08 | 0 | $0 | 210,863 | $4,299,879 | 535,710 | $8,101,565 |
| 2023-04 | 0 | $0 | 38,930 | $778,989 | 13,930 | $205,328 |
| 2023-03 | 0 | $0 | 93,160 | $1,587,874 | 67,860 | $662,656 |
| 2023-02 | 0 | $0 | 187,500 | $3,288,799 | 187,500 | $1,825,049 |
| 2023-01 | 0 | $0 | 0 | $0 | 100,000 | $420,000 |
| 2022-11 | 0 | $0 | 40,000 | $667,200 | 40,000 | $252,000 |
| 2022-09 | 0 | $0 | 40,000 | $717,600 | 40,000 | $248,400 |
| 2022-08 | 0 | $0 | 0 | $0 | 225,000 | $1,397,250 |
| 2022-05 | 0 | $0 | 76,812 | $1,489,826 | 40,000 | $125,200 |
| 2022-04 | 0 | $0 | 16,696 | $384,008 | 50,000 | $187,300 |
| 2022-03 | 0 | $0 | 49,301 | $1,067,621 | 50,000 | $187,300 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-21 | Heyman Tomas J. (Director) | Sale | 4,544 | 44.29 | 201,253 |
| 2025-05-20 | Haley Patrick J. (EVP, Commercial) | Sale | 34,387 | 44.06 | 1,515,091 |
| 2025-05-16 | Peterson Amy C. (EVP Prod Dev & Med Aff & CMO) | Sale | 72,776 | 45.47 | 3,309,124 |
| 2025-05-16 | Peterson Amy C. (EVP Prod Dev & Med Aff & CMO) | Option Ex | 40,000 | 21.75 | 870,000 |
| 2025-05-16 | Senner Christopher J. (EVP and CFO) | Sale | 100,000 | 46.00 | 4,600,000 |
| 2025-05-16 | Senner Christopher J. (EVP and CFO) | Option Ex | 100,000 | 18.80 | 1,880,000 |
| 2025-05-16 | Poste George (Director) | Sale | 20,634 | 45.99 | 948,957 |
| 2025-05-16 | Poste George (Director) | Option Ex | 20,634 | 19.77 | 407,934 |
| 2025-05-15 | Haley Patrick J. (EVP, Commercial) | Sale | 126,383 | 47.50 | 6,003,192 |
| 2025-05-15 | Haley Patrick J. (EVP, Commercial) | Option Ex | 116,383 | 18.80 | 2,188,000 |
| 2025-05-15 | Hessekiel Jeffrey (EVP & General Counsel) | Sale | 25,000 | 46.18 | 1,154,500 |
| 2025-05-15 | Papadopoulos Stelios (Director) | Sale | 36,508 | 44.35 | 1,619,129 |
| 2025-05-15 | Papadopoulos Stelios (Director) | Option Ex | 36,508 | 20.14 | 735,088 |
| 2025-05-14 | Haley Patrick J. (EVP, Commercial) | Sale | 10,000 | 42.68 | 426,800 |
| 2025-05-14 | Morrissey Michael (President and CEO) | Option Ex | 308,365 | 18.80 | 5,797,262 |
| 2025-05-01 | Aftab Dana (CSO/EVP Disc & Trans Research) | Sale | 1,508 | 39.00 | 58,812 |
| 2025-03-03 | Haley Patrick J. (EVP, Commercial) | Sale | 10,000 | 38.80 | 388,000 |
| 2025-02-28 | Smith Julie (Director) | Sale | 19,294 | 37.62 | 725,840 |
| 2025-02-28 | Smith Julie (Director) | Option Ex | 19,294 | 19.77 | 381,442 |
| 2025-02-28 | Wyszomierski Jack L (Director) | Sale | 8,768 | 37.80 | 331,430 |
| 2025-02-28 | Wyszomierski Jack L (Director) | Option Ex | 15,874 | 20.50 | 325,417 |
| 2025-02-27 | Smith Julie (Director) | Sale | 54,514 | 38.13 | 2,078,618 |
| 2025-02-27 | Smith Julie (Director) | Option Ex | 54,514 | 20.14 | 1,097,639 |
| 2025-02-25 | Oliver Bob (Director) | Sale | 18,647 | 37.25 | 694,600 |
| 2025-02-25 | Oliver Bob (Director) | Option Ex | 15,147 | 19.28 | 292,034 |
| 2025-02-24 | Aftab Dana (CSO/EVP Disc & Trans Research) | Sale | 26,987 | 36.75 | 991,772 |
| 2025-02-24 | Haley Patrick J. (EVP, Commercial) | Sale | 52,636 | 36.98 | 1,946,479 |
| 2025-02-24 | Senner Christopher J. (EVP and CFO) | Sale | 29,314 | 36.14 | 1,059,407 |
| 2025-02-24 | Senner Christopher J. (EVP and CFO) | Option Ex | 29,314 | 18.80 | 551,103 |
| 2025-02-14 | Eckhardt Sue Gail (Director) | Sale | 11,568 | 35.02 | 405,169 |
| 2025-02-14 | Eckhardt Sue Gail (Director) | Option Ex | 7,712 | 23.24 | 179,226 |
| 2025-02-14 | Freire Maria C (Director) | Sale | 44,114 | 34.94 | 1,541,343 |
| 2025-02-14 | Freire Maria C (Director) | Option Ex | 44,114 | 21.30 | 939,628 |
| 2025-02-14 | Beckerle Mary C (Director) | Sale | 12,210 | 34.88 | 425,945 |
| 2025-02-14 | Beckerle Mary C (Director) | Option Ex | 8,354 | 23.24 | 194,146 |
| 2025-02-14 | Poste George (Director) | Sale | 15,874 | 34.74 | 551,462 |
| 2025-02-14 | Poste George (Director) | Option Ex | 15,874 | 20.50 | 325,417 |
| 2024-11-29 | Hessekiel Jeffrey (EVP & General Counsel) | Sale | 60,000 | 36.67 | 2,200,200 |
| 2024-11-27 | Hessekiel Jeffrey (EVP & General Counsel) | Option Ex | 129,314 | 18.80 | 2,431,103 |
| 2024-11-22 | Haley Patrick J. (EVP, Commercial) | Sale | 10,000 | 35.27 | 352,700 |
| 2024-11-18 | Haley Patrick J. (EVP, Commercial) | Sale | 41,588 | 34.36 | 1,428,963 |
| 2024-11-05 | Aftab Dana (CSO/EVP Disc & Trans Research) | Sale | 96,986 | 35.00 | 3,394,510 |
| 2024-11-05 | Aftab Dana (CSO/EVP Disc & Trans Research) | Option Ex | 96,986 | 18.80 | 1,823,336 |
| 2024-11-01 | Hessekiel Jeffrey (EVP & General Counsel) | Sale | 50,000 | 34.13 | 1,706,500 |
| 2024-11-01 | Poste George (Director) | Sale | 30,000 | 34.00 | 1,020,000 |
| 2024-10-30 | Aftab Dana (CSO/EVP Disc & Trans Research) | Sale | 1,162 | 31.40 | 36,486 |
| 2024-10-28 | Hessekiel Jeffrey (EVP & General Counsel) | Sale | 25,000 | 28.39 | 709,750 |
| 2024-10-02 | Haley Patrick J. (EVP, Commercial) | Option Ex | 100,000 | 24.41 | 2,441,000 |
| 2024-10-01 | Morrissey Michael (President and CEO) | Option Ex | 480,000 | 24.41 | 11,716,800 |
| 2024-09-23 | Hessekiel Jeffrey (EVP & General Counsel) | Sale | 25,000 | 26.38 | 659,500 |
| 2024-08-26 | Hessekiel Jeffrey (EVP, General Counsel & Sec) | Sale | 20,000 | 25.79 | 515,800 |
| 2024-08-26 | Hessekiel Jeffrey (EVP, General Counsel & Sec) | Option Ex | 20,000 | 24.41 | 488,200 |
| 2024-08-14 | Freire Maria C (Director) | Sale | 8,250 | 26.56 | 219,120 |
| 2024-08-12 | Aftab Dana (CSO/EVP Disc & Trans Research) | Sale | 20,883 | 27.06 | 565,093 |
| 2024-08-09 | Senner Christopher J. (EVP and CFO) | Sale | 125,000 | 27.19 | 3,398,750 |
| 2024-08-09 | Senner Christopher J. (EVP and CFO) | Option Ex | 125,000 | 24.41 | 3,051,250 |
| 2024-08-08 | Poste George (Director) | Sale | 33,725 | 26.89 | 906,865 |
| 2024-08-07 | Aftab Dana (CSO/EVP Disc & Trans Research) | Sale | 95,000 | 25.00 | 2,375,000 |
| 2024-08-07 | Aftab Dana (CSO/EVP Disc & Trans Research) | Option Ex | 95,000 | 24.41 | 2,318,950 |
| 2024-08-07 | Haley Patrick J. (EVP, Commercial) | Sale | 14,000 | 25.50 | 357,000 |
| 2024-08-07 | Hessekiel Jeffrey (EVP, General Counsel & Sec) | Sale | 80,000 | 25.97 | 2,077,600 |
| 2024-08-07 | Hessekiel Jeffrey (EVP, General Counsel & Sec) | Option Ex | 80,000 | 24.41 | 1,952,800 |
| 2024-06-04 | Wyszomierski Jack L (Director) | Sale | 8,287 | 22.00 | 182,314 |
| 2024-05-30 | Caligan Partners Lp | Buy | 225,000 | 20.76 | 4,670,100 |
| 2024-05-28 | Caligan Partners Lp | Buy | 200,000 | 20.32 | 4,064,000 |
| 2024-05-21 | Smith Julie (Director) | Sale | 27,280 | 21.12 | 576,153 |
| 2024-05-21 | Poste George (Director) | Sale | 11,686 | 20.96 | 244,938 |
| 2024-05-21 | Poste George (Director) | Option Ex | 11,686 | 19.57 | 228,695 |
| 2024-05-20 | Papadopoulos Stelios (Director) | Sale | 11,437 | 21.00 | 240,177 |
| 2024-05-20 | Papadopoulos Stelios (Director) | Option Ex | 11,686 | 19.57 | 228,695 |
| 2024-05-13 | Wyszomierski Jack L (Director) | Sale | 10,923 | 21.37 | 233,424 |
| 2024-05-13 | Wyszomierski Jack L (Director) | Option Ex | 11,686 | 19.57 | 228,695 |
| 2024-03-21 | Garber Alan M (Director) | Sale | 19,205 | 24.01 | 461,112 |
| 2024-03-21 | Garber Alan M (Director) | Option Ex | 23,491 | 19.57 | 459,718 |
| 2024-02-23 | Haley Patrick J. (EVP, Commercial) | Sale | 47,020 | 21.45 | 1,008,579 |
| 2024-02-21 | Caligan Partners Lp | Buy | 190,000 | 20.70 | 3,932,810 |
| 2023-12-14 | Haley Patrick J. (EVP, Commercial) | Sale | 50,000 | 23.35 | 1,167,500 |
| 2023-12-14 | Haley Patrick J. (EVP, Commercial) | Option Ex | 50,000 | 16.29 | 814,500 |
| 2023-12-13 | Hessekiel Jeffrey (EVP, General Counsel & Sec) | Sale | 25,000 | 23.01 | 575,250 |
| 2023-12-12 | Haley Patrick J. (EVP, Commercial) | Sale | 14,149 | 22.50 | 318,352 |
| 2023-12-04 | Hessekiel Jeffrey (EVP, General Counsel & Sec) | Sale | 25,000 | 22.06 | 551,500 |
| 2023-11-30 | Hessekiel Jeffrey (EVP, General Counsel & Sec) | Sale | 25,000 | 22.01 | 550,250 |
| 2023-11-27 | Caligan Partners Lp | Buy | 120,409 | 21.61 | 2,602,038 |
| 2023-11-27 | Caligan Partners Lp | Sale | 120,409 | 21.61 | 2,602,038 |
| 2023-08-30 | Aftab Dana (CSO/EVP Disc & Trans Research) | Sale | 4,600 | 22.47 | 103,362 |
| 2023-08-28 | Morrissey Michael (President and CEO) | Option Ex | 360,000 | 15.31 | 5,511,600 |
| 2023-08-04 | Senner Christopher J. (EVP and CFO) | Sale | 60,000 | 20.68 | 1,240,800 |
| 2023-08-04 | Senner Christopher J. (EVP and CFO) | Option Ex | 60,000 | 14.74 | 884,400 |
| 2023-08-03 | Haley Patrick J. (EVP, Commercial) | Sale | 30,553 | 20.67 | 631,530 |
| 2023-08-03 | Senner Christopher J. (EVP and CFO) | Sale | 60,000 | 20.51 | 1,230,600 |
| 2023-08-03 | Senner Christopher J. (EVP and CFO) | Option Ex | 60,000 | 14.74 | 884,400 |
| 2023-08-01 | Hessekiel Jeffrey (EVP, General Counsel & Sec) | Sale | 55,710 | 19.63 | 1,093,587 |
| 2023-08-01 | Hessekiel Jeffrey (EVP, General Counsel & Sec) | Option Ex | 55,710 | 14.74 | 821,165 |
| 2023-04-05 | Hessekiel Jeffrey (EVP, General Counsel & Sec) | Sale | 38,930 | 20.01 | 778,989 |
| 2023-04-05 | Hessekiel Jeffrey (EVP, General Counsel & Sec) | Option Ex | 13,930 | 14.74 | 205,328 |
| 2023-03-10 | Wyszomierski Jack L | Sale | 15,300 | 16.61 | 254,133 |
| 2023-03-10 | Wyszomierski Jack L | Option Ex | 40,000 | 6.30 | 252,000 |
| 2023-03-01 | Hessekiel Jeffrey (EVP, General Counsel & Sec) | Sale | 77,860 | 17.13 | 1,333,741 |
| 2023-03-01 | Hessekiel Jeffrey (EVP, General Counsel & Sec) | Option Ex | 27,860 | 14.74 | 410,656 |
| 2023-02-28 | Aftab Dana (CSO/EVP Disc & Trans Research) | Sale | 82,490 | 17.50 | 1,443,575 |
| 2023-02-28 | Aftab Dana (CSO/EVP Disc & Trans Research) | Option Ex | 82,490 | 14.74 | 1,215,902 |
| 2023-02-27 | Aftab Dana (CSO/EVP Disc & Trans Research) | Sale | 10 | 17.50 | 175 |
| 2023-02-27 | Aftab Dana (CSO/EVP Disc & Trans Research) | Option Ex | 10 | 14.74 | 147 |
| 2023-02-21 | Garber Alan M | Sale | 40,000 | 17.49 | 699,599 |
| 2023-02-21 | Garber Alan M | Option Ex | 40,000 | 6.30 | 252,000 |
| 2023-02-09 | Feldbaum Carl B | Sale | 40,000 | 17.78 | 711,200 |
| 2023-02-09 | Feldbaum Carl B | Option Ex | 40,000 | 6.30 | 252,000 |
| 2023-02-06 | Haley Patrick J. (EVP, Commercial) | Sale | 25,000 | 17.37 | 434,250 |
| 2023-02-06 | Haley Patrick J. (EVP, Commercial) | Option Ex | 25,000 | 4.20 | 105,000 |
| 2023-01-24 | Morrissey Michael (President and CEO) | Option Ex | 100,000 | 4.20 | 420,000 |
| 2022-11-29 | Poste George | Sale | 40,000 | 16.68 | 667,200 |
| 2022-11-29 | Poste George | Option Ex | 40,000 | 6.30 | 252,000 |
| 2022-09-12 | Haley Patrick J. (EVP, Commercial) | Sale | 40,000 | 17.94 | 717,600 |
| 2022-09-12 | Haley Patrick J. (EVP, Commercial) | Option Ex | 40,000 | 6.21 | 248,400 |
| 2022-08-11 | Senner Christopher J. (EVP and CFO) | Option Ex | 225,000 | 6.21 | 1,397,250 |
| 2022-05-27 | Haley Patrick J. (EVP, Commercial) | Sale | 18,812 | 18.21 | 342,566 |
| 2022-05-16 | Hessekiel Jeffrey (EVP, General Counsel & Sec) | Sale | 18,000 | 20.07 | 361,260 |
| 2022-05-12 | Willsey Lance | Sale | 40,000 | 19.65 | 786,000 |
| 2022-05-12 | Willsey Lance | Option Ex | 40,000 | 3.13 | 125,200 |
| 2022-04-04 | Wyszomierski Jack L | Sale | 6,696 | 23.00 | 154,008 |
| 2022-04-04 | Wyszomierski Jack L | Option Ex | 40,000 | 3.13 | 125,200 |
| 2022-04-01 | Haley Patrick J. (EVP, Commercial) | Sale | 10,000 | 23.00 | 230,000 |
| 2022-04-01 | Haley Patrick J. (EVP, Commercial) | Option Ex | 10,000 | 6.21 | 62,100 |
| 2022-03-31 | Haley Patrick J. (EVP, Commercial) | Sale | 10,000 | 22.43 | 224,300 |
| 2022-03-31 | Haley Patrick J. (EVP, Commercial) | Option Ex | 10,000 | 6.21 | 62,100 |
| 2022-03-29 | Hessekiel Jeffrey (EVP, General Counsel & Sec) | Sale | 13,283 | 22.00 | 292,226 |
| 2022-03-28 | Hessekiel Jeffrey (EVP, General Counsel & Sec) | Sale | 4,717 | 22.00 | 103,774 |
| 2022-03-01 | Garber Alan M | Sale | 21,301 | 21.00 | 447,321 |
| 2022-03-01 | Garber Alan M | Option Ex | 40,000 | 3.13 | 125,200 |
| 2022-02-25 | Haley Patrick J. (EVP, Commercial) | Sale | 31,238 | 19.53 | 610,078 |
| 2022-02-24 | Hessekiel Jeffrey (EVP and General Counsel) | Sale | 18,000 | 20.00 | 360,000 |
| 2022-02-22 | Feldbaum Carl B | Sale | 20,000 | 19.49 | 389,799 |
| 2022-02-22 | Feldbaum Carl B | Option Ex | 20,000 | 3.13 | 62,600 |
| 2022-02-22 | Papadopoulos Stelios | Sale | 84,515 | 19.56 | 1,653,113 |
| 2022-02-03 | Haley Patrick J. (EVP, Commercial) | Sale | 60,000 | 17.91 | 1,074,600 |
| 2022-02-03 | Haley Patrick J. (EVP, Commercial) | Option Ex | 60,000 | 1.90 | 114,000 |
| 2021-12-15 | Lamb Peter (EVP, Scientific Strategy & CSO) | Sale | 47,500 | 17.44 | 828,400 |
| 2021-12-15 | Lamb Peter (EVP, Scientific Strategy & CSO) | Option Ex | 47,500 | 6.21 | 294,975 |
| 2021-11-24 | Haley Patrick J. (EVP, Commercial) | Sale | 17,236 | 17.25 | 297,321 |
| 2021-11-19 | Feldbaum Carl B | Sale | 20,000 | 17.62 | 352,400 |
| 2021-11-19 | Feldbaum Carl B | Option Ex | 20,000 | 3.13 | 62,600 |
| 2021-11-15 | Lamb Peter (EVP, Scientific Strategy & CSO) | Sale | 47,500 | 18.09 | 859,275 |
| 2021-11-15 | Lamb Peter (EVP, Scientific Strategy & CSO) | Option Ex | 47,500 | 6.21 | 294,975 |
| 2021-11-01 | Hessekiel Jeffrey (EVP and General Counsel) | Sale | 5,117 | 22.03 | 112,727 |
| 2021-10-15 | Hessekiel Jeffrey (EVP and General Counsel) | Sale | 12,883 | 22.02 | 283,683 |
| 2021-10-15 | Lamb Peter (EVP, Scientific Strategy & CSO) | Sale | 47,500 | 21.92 | 1,041,200 |
| 2021-10-15 | Lamb Peter (EVP, Scientific Strategy & CSO) | Option Ex | 47,500 | 6.21 | 294,975 |
| 2021-09-21 | Senner Christopher J. (EVP and CFO) | Option Ex | 90,000 | 3.66 | 329,400 |
| 2021-09-16 | Haley Patrick J. (EVP, Commercial) | Sale | 25,000 | 20.36 | 509,000 |
| 2021-09-16 | Haley Patrick J. (EVP, Commercial) | Option Ex | 25,000 | 1.70 | 42,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of EXEL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Exelixis, Inc. (symbol EXEL, CIK number 939767) see the Securities and Exchange Commission (SEC) website.